Trial Profile
Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2014
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Open-angle glaucoma
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 27 Nov 2014 New trial record